DE69110254D1 - Hydroxychinolonderivate. - Google Patents

Hydroxychinolonderivate.

Info

Publication number
DE69110254D1
DE69110254D1 DE69110254T DE69110254T DE69110254D1 DE 69110254 D1 DE69110254 D1 DE 69110254D1 DE 69110254 T DE69110254 T DE 69110254T DE 69110254 T DE69110254 T DE 69110254T DE 69110254 D1 DE69110254 D1 DE 69110254D1
Authority
DE
Germany
Prior art keywords
hydroxyquinolone
derivatives
hydroxyquinolone derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69110254T
Other languages
English (en)
Other versions
DE69110254T2 (de
Inventor
William R Carling
Paul D Leeson
Kevin W Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Application granted granted Critical
Publication of DE69110254D1 publication Critical patent/DE69110254D1/de
Publication of DE69110254T2 publication Critical patent/DE69110254T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69110254T 1990-12-05 1991-11-27 Hydroxychinolonderivate. Expired - Fee Related DE69110254T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909026389A GB9026389D0 (en) 1990-12-05 1990-12-05 Therapeutic agents

Publications (2)

Publication Number Publication Date
DE69110254D1 true DE69110254D1 (de) 1995-07-13
DE69110254T2 DE69110254T2 (de) 1996-01-04

Family

ID=10686486

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69110254T Expired - Fee Related DE69110254T2 (de) 1990-12-05 1991-11-27 Hydroxychinolonderivate.

Country Status (6)

Country Link
US (1) US5252584A (de)
EP (1) EP0489458B1 (de)
JP (1) JPH0784460B2 (de)
CA (1) CA2056808A1 (de)
DE (1) DE69110254T2 (de)
GB (1) GB9026389D0 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622965A (en) * 1993-03-12 1997-04-22 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists
US5526840A (en) * 1993-05-24 1996-06-18 Courtaulds Fibres (Holdings) Limited Emergency dump tank for congealable materials
US5475007A (en) * 1993-05-28 1995-12-12 The Regents Of The University Of California 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and the use thereof
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
EP0685466A1 (de) * 1994-06-02 1995-12-06 Ciba-Geigy Ag 3-Heteroaliphatyl- und 3-Hetero-(aryl)aliphatyl-2(1H)-chinolonderivate
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
FR2722989B1 (fr) * 1994-07-29 1997-05-30 Synthelabo Utilisation de l'ifenprodil et de ses enantiomeres pour la preparation de medicaments utiles dans le traitement des neuropathies peripheriques et des maladies neurodegeneratives centrales
US5801183A (en) * 1995-01-27 1998-09-01 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists
US5773434A (en) * 1995-08-30 1998-06-30 Gary A. Rogers Facilitation of AMPA receptor-mediated synaptic transmission in brain as a treatment for schizophrenia
ATE227293T1 (de) * 1996-05-15 2002-11-15 Pfizer 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
CA2254769A1 (en) * 1996-05-20 1997-11-27 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
ATE229004T1 (de) * 1997-03-31 2002-12-15 Korea Res Inst Chem Tech Chinolinische sulfid-derivate als nmda rezeptor- antagonisten und verfahren zu ihrer herstellung
US6962930B1 (en) 1997-06-06 2005-11-08 Lohocla Research Corporation Compounds, compositions and method suitable for amelioration of withdrawal syndromes and withdrawal-induced brain damage
US5783700A (en) * 1997-07-03 1998-07-21 Nichols; Alfred C. Quinolic acid derivatives
IL125950A0 (en) * 1997-09-05 1999-04-11 Pfizer Prod Inc Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
US6323208B1 (en) 1997-09-05 2001-11-27 Pfizer Inc Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones
JP2000309585A (ja) 1999-02-26 2000-11-07 Kyorin Pharmaceut Co Ltd ６−置換ヘテロキノリンカルボン酸誘導体とその付加塩及びそれらの製造方法
US6710058B2 (en) 2000-11-06 2004-03-23 Bristol-Myers Squibb Pharma Company Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
US6998408B2 (en) * 2001-03-23 2006-02-14 Bristol-Myers Squibb Pharma Company 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
AR033485A1 (es) * 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
US6822097B1 (en) * 2002-02-07 2004-11-23 Amgen, Inc. Compounds and methods of uses
MX2009006077A (es) * 2007-01-08 2009-06-17 Suven Life Sciences Ltd Compuestos de 5-(heterociclil)alquil-n-(arilsulfonil)indol y su uso como ligandos de la 5-hidroxitriptamina6.
TWI366565B (en) 2007-06-06 2012-06-21 Otsuka Pharma Co Ltd Quinolone compound and pharmaceutical composition
US20160368897A1 (en) * 2013-06-28 2016-12-22 Emory University Pyrazoline Dihydroquinolones, Pharmaceutical Compositions, and Uses
FR3055331B1 (fr) * 2016-08-31 2020-03-06 Adpuerivitam Modulateurs de recepteurs nmda, compositions les comprenant et utilisation de ces composes dans le traitement de maladies impliquant le systeme nerveux central
WO2019191424A1 (en) 2018-03-28 2019-10-03 Emory University Glun2c/d subunit selective antagonists of the n-methyl-d-aspartate receptor
AU2021275994A1 (en) * 2020-05-21 2022-12-22 Stemsynergy Therapeutics, Inc. Notch inhibitors and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574216A (en) * 1968-04-12 1971-04-06 American Home Prod Quaternary 3-pyridinium-2-quinolones
JPS5736952B2 (de) * 1974-06-14 1982-08-06
US4119720A (en) * 1977-07-06 1978-10-10 Sandoz, Inc. Unsaturated esters of 4-hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
US4362876A (en) * 1978-08-11 1982-12-07 The Sherwin-Williams Company Preparation of dihydroxyquinoline and certain derivatives
US4735948A (en) * 1983-03-25 1988-04-05 Merrell Dow Pharmaceuticals Inc. (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
JPH068292B2 (ja) * 1985-05-07 1994-02-02 アルカロイダ ベギエスゼティ ギャル トリアゾリルキノリン誘導体
US4684727A (en) * 1985-07-29 1987-08-04 Schering Corporation Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents
GB8719102D0 (en) * 1987-08-12 1987-09-16 Merck Sharp & Dohme Therapeutic agents
DD269382A1 (de) * 1988-03-07 1989-06-28 Univ Dresden Tech Verfahren zur herstellung von 3-amino-4-hydroxy-chinol-2-onen
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
US5039528A (en) * 1989-12-11 1991-08-13 Olney John W EAA antagonists as anti-emetic drugs
US5175151A (en) * 1990-09-07 1992-12-29 Schering Corporation Antiviral compounds and antihypertensive compounds

Also Published As

Publication number Publication date
EP0489458B1 (de) 1995-06-07
GB9026389D0 (en) 1991-01-23
EP0489458A1 (de) 1992-06-10
DE69110254T2 (de) 1996-01-04
JPH069618A (ja) 1994-01-18
US5252584A (en) 1993-10-12
JPH0784460B2 (ja) 1995-09-13
CA2056808A1 (en) 1992-06-06

Similar Documents

Publication Publication Date Title
NL300250I1 (nl) Chinuclidinederivaten.
FI920790A0 (fi) Handfrigoeringsmodul.
DE69112037T2 (de) Waferträger.
DE69110254D1 (de) Hydroxychinolonderivate.
FI903024A0 (fi) Tvaoskiktad pappersmaskinsduk.
DE69111876T2 (de) Ophthalmometer.
FI86263B (fi) Skaer- och slipanordning foer en glasskivkant.
FI86244B (fi) Bakugn-spisugnkombination.
DE59104521D1 (de) Polkern.
FI87009B (fi) Skovelhjul foer centrifugalpumpar.
FI914078A0 (fi) Fluorklorkolvaetefria rengoeringssammansaettningar.
FI911041A0 (fi) Vanersammansaettning.
DE69100071D1 (de) Kaefigmutter.
DE59106761D1 (de) N-Acylpyrrolidin-Derivate.
ATE124392T1 (de) 8-sulfamylmethylen-2-aminotetraline.
FI900028A0 (fi) Belaeggningsmaterial.
DE59103525D1 (de) Honmachine.
DE59100113D1 (de) Rollcontainer.
DE69104797D1 (de) 2-Substituierte-1-Hydroxyindole.
FI900060A (fi) Vinstfoerdelningsport foer en spelanordning.
DE69109531T2 (de) 4-Piperidinyl-ergolin-Derivate.
DE69106651D1 (de) KS-505-Derivate.
DE59101556D1 (de) Propellane.
ES1017193Y (es) Cubre-bidet.
ES1019974Y (es) Capazo-cuna.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee